Join us in shaping the future of cardiovascular care across DACH. As DACH Medical Lead, you will lead our regional medical organisation, build trusted scientific relationships, drive launch readiness, and ensure strong medical leadership across Germany, Austria and Switzerland.
Abacus Medicine Pharmaceuticals is strengthening its medical presence across Europe, and we are looking for a DACH Medical Lead to lead our cardiovascular medical activities across Germany, Austria and Switzerland. In this role, you will translate global medical strategy into regional and country-specific execution, ensuring healthcare professionals, treatment centres and internal stakeholders are informed, prepared and confident in the use of AMP’s medicines.
You will hold end-to-end medical accountability for DACH and lead a team of 3–4 Medical Advisers / MSLs across the region. Working at the intersection of global medical strategy, local clinical practice and external scientific engagement, you will be responsible for launch readiness, scientific relationships, medical governance, evidence generation and the development of a strong field medical organisation.
This is a non-promotional role with no commercial performance targets. Medical decisions are made on scientific and patient-safety grounds, while you will partner closely with commercial and cross-functional colleagues.
You are an experienced Medical Affairs leader who combines strong scientific judgement with credible people leadership and the ability to operate across multiple markets. You can build trusted relationships with senior scientific stakeholders while setting clear direction for a regional medical team.
You are comfortable working at the intersection of science and business, maintaining medical independence while partnering effectively across functions. With a structured and pragmatic approach, you can translate global strategy into focused regional execution and build capabilities in a growing organisation.
You will join Global Medical Affairs in Abacus Medicine Pharmaceuticals and take direct leadership responsibility for 3–4 Medical Advisers / MSLs across Germany, Austria and Switzerland. Together, you will build a strong DACH medical presence and ensure consistent, scientifically credible and compliant medical engagement across the region.
You will work closely with colleagues across Evidence Generation, Medical Information, Pharmacovigilance, Regulatory Affairs, Quality, Legal, Compliance, Supply and Operations, Commercial and Market Access. Externally, you will engage with cardiovascular KOLs, healthcare professionals, treatment centres, scientific societies, health authorities, HTA bodies, payers and other relevant healthcare stakeholders.
As part of a growing Pharma division, you will have the opportunity to shape not only our medical activities across DACH, but also the team, capabilities and ways of working behind them. You will join an international environment where scientific integrity, collaboration and an entrepreneurial mindset help drive meaningful outcomes for patients and healthcare systems.
If you want to apply for the position, please follow the link and attach your CV.
If you have any further questions about the role, please do not hesitate to contact the Talent Acquisition Partner, Victor, at victor.weyen@abacusmedicine.com.
Would you like to know more about us?
Follow us on Instagram and LinkedIn and get an insight into everyday life at Abacus Medicine. For job openings, check our Career page.
In Abacus Medicine Group, you’ll experience the power of Moving Healthcare. With our change mindset, we're moving the industry and improving healthcare as we broaden access to medicine.
But it's not just about moving healthcare, it's about Moving You. You’ll be part of a caring community of around 2,000 people across the World. With us, you will be valued, empowered, and have a direct impact on driving change. Let's access the future of medicine and make a difference together. Your move.

Even the best medicine in the world won’t work if it never reaches the patient, and insufficient access is a large and growing problem.
The Abacus Medicine Group offers a range of different solutions and services that provide better access to life-critical medicine at affordable prices to millions of patients across the world. Our business purpose holds a substantial positive impact on healthcare systems and society and is something we're proud of.
The company was founded in 2004 by CEO Flemming Wagner and Medical Director John Wagner and has experienced significant growth ever since. Today, we are more than 1,500 colleagues moving healthcare in Europe and beyond.
The Abacus Medicine Group is among the 100 largest Danish companies.
The Group operates as four brands: Abacus Medicine, Pluripharm, Abacus Medicine Pharma Services and Originalis.
Learn more about the Abacus Medicine Group on our website below.